BioLineRx inks stock sale agreement with institutional investor

BioLineRx (BLRX -1.4%) signs a 36-month purchase agreement for the sale, from time to time, of up to $20M of its ADSs to Lincoln Park Capital Fund LLC. The timing and amount of the sales are at the sole discretion of BLRX and the agreement can be terminated at any time without cost or penalty.

Under the terms of the agreement, BLRX will maintain an effective registration statement with the SEC for all shares sold.

Comments (2)
  • nsahbti
    , contributor
    Comments (38) | Send Message
    At what price per share?
    30 May 2014, 11:16 AM Reply Like
  • vovc
    , contributor
    Comments (3) | Send Message
    biolinerx doing endless share dilution again and again when you stop
    to doing this?
    30 May 2014, 01:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs